Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
暂无分享,去创建一个
E. Srivatsan | R. Wilken | Marilene B. Wang | Marilene B Wang | Reason Wilken | Mysore S Veena | Eri S Srivatsan | M. Veena
[1] Vasudha Sundram,et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth , 2010, Journal of ovarian research.
[2] H. Ohshima,et al. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.
[3] L. Harhaji-Trajković,et al. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells , 2009, Journal of cellular and molecular medicine.
[4] Wei-dong Cao,et al. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma , 2007, Journal of Neuro-Oncology.
[5] J. Duyster,et al. The anticancer drug imatinib induces cellular autophagy , 2007, Leukemia.
[6] G. Caldito,et al. Curcumin Inhibits Carcinogen and Nicotine-Induced Mammalian Target of Rapamycin Pathway Activation in Head and Neck Squamous Cell Carcinoma , 2010, Cancer Prevention Research.
[7] Sujay K. Singh,et al. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signaling , 2004 .
[8] P. Yeh,et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. , 2002, Biochemical pharmacology.
[9] Q. Liu,et al. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[10] D. Shoskes,et al. The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair. , 2000, The Journal of urology.
[11] H. Lee,et al. Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells , 2007, Melanoma research.
[12] Olufunmilayo I. Olopade,et al. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Yoshio Masui,et al. Understanding the cell cycle , 1998, Nature Medicine.
[14] R. Herbst,et al. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies , 2008, Cancer.
[15] C. Van Waes,et al. Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines , 1999, Molecular carcinogenesis.
[16] S. Lippman,et al. Head and Neck Cancer , 1993, Cancer treatment and research.
[17] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[18] S. Shankar,et al. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis , 2008, Molecular Cancer.
[19] Chatchawan Changtam,et al. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. , 2008, World journal of gastroenterology.
[20] Alex Starr,et al. Curcumin: A potential radio‐enhancer in head and neck cancer , 2009, The Laryngoscope.
[21] U. Schumacher,et al. Curcumin Induces Apoptosis in Human Neuroblastoma Cells via Inhibition of NFκB , 2008 .
[22] Stell Pm. Survival times in end-stage head and neck cancer. , 1989 .
[23] B. Aggarwal,et al. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.
[24] Murugesan V. S. Rajaram,et al. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK , 2007, Cancer biology & therapy.
[25] C. Van Waes,et al. Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer , 2009, Clinical Cancer Research.
[26] C. Yeh,et al. Inhibition of NFκB Activation with Curcumin Attenuates Plasma Inflammatory Cytokines Surge and Cardiomyocytic Apoptosis Following Cardiac Ischemia/Reperfusion1 , 2005 .
[27] J. Mathers,et al. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. , 2001, Carcinogenesis.
[28] Ying-Jan Wang,et al. Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis , 2010, Autophagy.
[29] E. Lander,et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.
[30] M. Hidalgo,et al. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] R. Delston,et al. Rb at the interface between cell cycle and apoptotic decisions. , 2006, Current molecular medicine.
[32] T. Horie,et al. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.
[33] T. Gilmore. Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.
[34] L. Platanias,et al. Curcumin suppresses constitutive activation of nuclear factor-κB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines , 2008, Molecular Cancer Therapeutics.
[35] Xiaoping Yang,et al. Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[36] Yuetsu Tanaka,et al. Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells , 2006 .
[37] Chul-hak Yang,et al. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues. , 2005, Journal of biochemistry and molecular biology.
[38] M. Kawakami,et al. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma. , 2007, Oncology reports.
[39] Yihai Cao,et al. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. , 2007, Advances in cancer research.
[40] M. Ewen,et al. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.
[41] Sung-Chul Lim,et al. The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer* , 2010, The Journal of Biological Chemistry.
[42] Mansoor M Ahmed,et al. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 , 2004, Oncogene.
[43] Zhiwei Wang,et al. Synergistic effects of multiple natural products in pancreatic cancer cells. , 2008, Life sciences.
[44] Gang Wu,et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy. , 2010, Cancer biotherapy & radiopharmaceuticals.
[45] R. Lotan,et al. Differential Inhibition of Protein Translation Machinery by Curcumin in Normal, Immortalized, and Malignant Oral Epithelial Cells , 2010, Cancer Prevention Research.
[46] J. S. Buzby,et al. Curcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo , 2010, Brain Research.
[47] Lixin Wei,et al. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells , 2009, Autophagy.
[48] U. Schumacher,et al. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. , 2008, Anticancer research.
[49] M. Russo,et al. Role of hypoxia and autophagy in MDA‐MB‐231 invasiveness , 2010, Journal of cellular physiology.
[50] Sujay K. Singh,et al. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .
[51] I. Germano,et al. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. , 2003, Cancer research.
[52] C. Rao. Regulation of COX and LOX by curcumin. , 2007, Advances in experimental medicine and biology.
[53] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[54] K. Mohandas,et al. Epidemiology of digestive tract cancers in India. VI. Projected burden in the new millennium and the need for primary prevention. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[55] I. Mackenzie,et al. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[56] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .
[57] S. Paek,et al. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase , 2010, International journal of cancer.
[58] B. Aggarwal,et al. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. , 1997, Anti-cancer drugs.
[59] M. Posner. Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[60] N. Colburn,et al. Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis , 2000 .
[61] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[62] A. Mobasheri,et al. Effects of Curcumin (Diferuloylmethane) on Nuclear Factor κB Signaling in Interleukin‐1β‐Stimulated Chondrocytes , 2004 .
[63] Namitha,et al. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. , 2005, The Indian journal of medical research.
[64] Y. Oda. Inhibitory effect of curcumin on SOS functions induced by UV irradiation. , 1995, Mutation research.
[65] Jordi Giralt,et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.
[66] K. Mohandas,et al. Epidemiology of digestive tract cancers in India. V. Large and small bowel. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[67] Stephen J. Elledge,et al. Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.
[68] T. Masuda,et al. Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. , 2001, Journal of agricultural and food chemistry.
[69] Sanjeev Banerjee,et al. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation , 2002, Oncogene.
[70] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[71] Gang Li,et al. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. , 2001, Experimental cell research.
[72] T. Das,et al. Anti cancer effects of curcumin: cycle of life and death , 2008, Cell Division.
[73] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[74] Bao Q. Pham,et al. Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B* , 2000, The Journal of Biological Chemistry.
[75] E. Wagner,et al. JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression , 2000, The EMBO journal.
[76] J. Milner,et al. Diet, Autophagy, and Cancer: A Review , 2008, Cancer Epidemiology Biomarkers & Prevention.
[77] W. Bursch,et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. , 1996, Carcinogenesis.
[78] H. Phelan,et al. Large and Small Bowel , 2012 .
[79] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[80] Yi-Song Wang,et al. bcl-2 inhibits wild-type p53-triggered apoptosis but not G1 cell cycle arrest and transactivation of WAF1 and bax. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[81] H. Won,et al. Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. , 2009, Journal of pharmacological sciences.
[82] Neeta Singh,et al. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells , 2009, Molecular and Cellular Biochemistry.
[83] Y. Surh,et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.
[84] A. D. Caballero,et al. Oral sequelae of head and neck radiotherapy , 2011 .
[85] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[86] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.
[87] Razelle Kurzrock,et al. Liposome‐encapsulated curcumin , 2005, Cancer.
[88] B. Aggarwal,et al. Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.
[89] B. Ghosh,et al. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. , 2003, Biological & pharmaceutical bulletin.
[90] T. Mikkelsen,et al. The induction of autophagy by γ‐radiation contributes to the radioresistance of glioma stem cells , 2009, International journal of cancer.
[91] S. Suresh,et al. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. , 2009, The Journal of pharmacy and pharmacology.
[92] E. Vokes,et al. Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy , 2004, Clinical Cancer Research.
[93] C. Thompson,et al. Death by design: apoptosis, necrosis and autophagy. , 2004, Current opinion in cell biology.
[94] P. Angel,et al. AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.
[95] A. Senderowicz. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms , 2003, Cancer Chemotherapy and Pharmacology.
[96] N. Perkins,et al. Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.
[97] R. Béliveau,et al. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. , 2010, Molecular nutrition & food research.
[98] Shandar Ahmad,et al. Curcumin inhibits NFκB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. , 2008 .
[99] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[100] B. Aggarwal,et al. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. , 2010, European journal of pharmacology.
[101] B. Joe,et al. Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action , 2004, Critical reviews in food science and nutrition.
[102] C. Rhee,et al. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. , 2002, International journal of oncology.
[103] F. Mollinedo,et al. Cytoskeleton-mediated Death Receptor and Ligand Concentration in Lipid Rafts Forms Apoptosis-promoting Clusters in Cancer Chemotherapy* , 2005, Journal of Biological Chemistry.
[104] Jie Jin,et al. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. , 2007, Leukemia research.
[105] M. Rhee,et al. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. , 2006, Life sciences.
[106] B. Ramesh,et al. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. , 2007, European journal of pharmacology.
[107] A. Conney,et al. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.
[108] R. Shen,et al. A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer , 2011, Cancer.
[109] B. Ray,et al. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. , 2009, Current opinion in pharmacology.
[110] Y. Kondo,et al. Roles of the Akt/mTOR/p70S6K and ERK1/2 Signaling Pathways in Curcumin-Induced Autophagy , 2007, Autophagy.
[111] B. Aggarwal,et al. Targeting constitutive and interleukin‐6‐inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane) , 2006, International journal of cancer.
[112] J. Dancey,et al. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. , 2009, The Lancet. Oncology.
[113] K. Srinivasan,et al. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat , 1995, Molecular and Cellular Biochemistry.
[114] L. Avery,et al. To be or not to be, the level of autophagy is the question: Dual roles of autophagy in the survival response to starvation , 2008, Autophagy.
[115] A. Brasier. The NF-κB regulatory network , 2007, Cardiovascular Toxicology.
[116] B. Aggarwal,et al. Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: correlation with induction of cyclooxygenase-2 , 2002 .
[117] C. Bokemeyer,et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.
[118] B. Aggarwal,et al. Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway , 2005, Cancer.
[119] E. Srivatsan,et al. Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway , 2008, Clinical Cancer Research.
[120] J. Bourhis,et al. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[121] I. Weissman,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.
[122] Tirunelveli S. Ramalingam,et al. Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.
[123] T. Gilmore,et al. The Rel/NF-κB signal transduction pathway: introduction , 1999, Oncogene.
[124] Amy Y. Chen,et al. Longitudinal oncology registry of head and neck carcinoma (LORHAN) , 2011, Cancer.
[125] Sylvia B. Smith,et al. A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance , 2008, Molecular Cancer Therapeutics.
[126] R. Kurzrock,et al. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer , 2007, Molecular Cancer Therapeutics.
[127] G. Donzelli,et al. Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kappaB, and JNK pathways. , 2008, Free radical biology & medicine.
[128] B. Aggarwal,et al. Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.
[129] M. Dyer,et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. , 2009, The Journal of clinical investigation.
[130] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[131] A. Maitra,et al. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. , 2009, Current drug discovery technologies.
[132] M. Leblanc,et al. Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[133] G. Caldito,et al. Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma , 2009, Molecular Cancer Therapeutics.
[134] B. Joe,et al. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.
[135] Anupama E. Gururaj,et al. Molecular mechanisms of anti-angiogenic effect of curcumin. , 2002, Biochemical and biophysical research communications.
[136] T. Elattar,et al. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. , 2000, Anticancer research.
[137] A. Mobasheri,et al. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. , 2004, Annals of the New York Academy of Sciences.
[138] M. Fan,et al. Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells. , 2009, Oncology reports.
[139] Yung-Hyun Choi,et al. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. , 2008, Biochemical and biophysical research communications.
[140] J. Price,et al. Curcumin Suppresses the Paclitaxel‐Induced Nuclear Factor‐κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model , 2009, The breast journal.
[141] S. Wilhelm,et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.
[142] E. Schleicher,et al. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. , 2008, Carcinogenesis.
[143] Z. Qin,et al. The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells , 2009, BMC Cancer.
[144] M. Berger,et al. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells , 2007, Cell Death and Differentiation.
[145] S. Ray,et al. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. , 2003, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[146] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[147] B. Rigas,et al. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. , 1997, The Journal of laboratory and clinical medicine.
[148] Govind Bhagat,et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.
[149] T. Kondo,et al. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[150] M. Rao,et al. Curcuminoids as Potent Inhibitors of Lipid Peroxidation , 1994, The Journal of pharmacy and pharmacology.
[151] Sujay K. Singh,et al. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. , 2003, Blood.
[152] Liz Y. Han,et al. Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway , 2007, Clinical Cancer Research.
[153] Y. Song,et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. , 2003, Carcinogenesis.
[154] Shu-Chun Lin,et al. Curcumin upregulates insulin‐like growth factor binding protein‐5 (IGFBP‐5) and C/EBPα during oral cancer suppression , 2010, International journal of cancer.
[155] B. Aggarwal,et al. Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways , 2007, Molecular Pharmacology.
[156] J. Moon,et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216) , 2009, Head & neck.
[157] S. Onodera,et al. Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.
[158] Julie S. Jurenka. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.
[159] Editors-in-Chief C. Nicot. Molecular Cancer , 2009 .
[160] S. McKenna,et al. Curcumin induces apoptosis-independent death in oesophageal cancer cells , 2009, British Journal of Cancer.
[161] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[162] S. Gultekin,et al. Autophagy in human tumors: cell survival or death? , 2004, Cell Death and Differentiation.
[163] Sanjeev Banerjee,et al. Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.
[164] U. Bandyopadhyay,et al. Turmeric and curcumin: Biological actions and medicinal applications , 2004 .
[165] E. Srivatsan,et al. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. , 2006, Archives of otolaryngology--head & neck surgery.
[166] N. Maitland,et al. Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.
[167] Arnold J. Levine,et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[168] B. Aggarwal,et al. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. , 2010, Biochemical pharmacology.
[169] R. Kurzrock,et al. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. , 2009, Anticancer research.
[170] G. Jagetia. Radioprotection and radiosensitization by curcumin. , 2007, Advances in experimental medicine and biology.
[171] N. Altorki,et al. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. , 1999, Carcinogenesis.
[172] V. Steele,et al. Targeting the AKT protein kinase for cancer chemoprevention , 2007, Molecular Cancer Therapeutics.
[173] D. Gewirtz,et al. Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[174] Yuetsu Tanaka,et al. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. , 2006, International journal of cancer.
[175] B. Conley,et al. Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects , 2009, Current opinion in oncology.
[176] J. Rhim,et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. , 2002, International journal of oncology.
[177] S. Okada,et al. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. , 2003, Pharmacology & toxicology.
[178] B. Aggarwal,et al. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.
[179] Sushovan Guha,et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. , 2009, International journal of radiation oncology, biology, physics.
[180] G. Maru,et al. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[181] P. Matarrese,et al. Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells , 2007, FEBS letters.
[182] S. Shankar,et al. Linkage of Curcumin-Induced Cell Cycle Arrest and Apoptosis by Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 , 2007, Cell cycle.
[183] O. Werz,et al. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1 , 2009, Molecular Cancer Therapeutics.
[184] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[185] C. Yeh,et al. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. , 2005, The Journal of surgical research.
[186] M. Chan,et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.
[187] S. Chakrabarti,et al. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. , 2009, Nutrition.
[188] T. Motyl,et al. Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel , 2005, Anti-cancer drugs.
[189] H. Hibshoosh,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.
[190] Y. Surh,et al. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. , 2002, Journal of biochemistry and molecular biology.
[191] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[192] Z. Qin,et al. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells , 2009, Journal of Asian natural products research.
[193] J. Lin,et al. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[194] J. Grandis,et al. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells , 2008, Molecular Cancer Therapeutics.
[195] E. Vokes,et al. The expanding role of systemic therapy in head and neck cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[196] C. Van Waes,et al. Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer , 2008, Clinical Cancer Research.
[197] C. Kartha,et al. Curcumin Attenuates Glucose-Induced Monocyte Chemoattractant Protein-1 Synthesis in Aortic Endothelial Cells by Modulating the Nuclear Factor-ĸB Pathway , 2009, Pharmacology.
[198] N. Colburn,et al. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. , 2000, Free radical biology & medicine.
[199] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[200] J. Bussink,et al. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. , 2008, The Lancet. Oncology.
[201] A Garg,et al. Nuclear transcription factor-κB as a target for cancer drug development , 2002, Leukemia.
[202] T. Ciuleanu,et al. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients , 2009, Cancer Chemotherapy and Pharmacology.
[203] S. Pandol,et al. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[204] G. Peters,et al. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.
[205] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[206] E. Srivatsan,et al. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. , 2009, Archives of otolaryngology--head & neck surgery.
[207] Jennifer L Hunt,et al. Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting , 2006, Clinical Cancer Research.
[208] H. Niimi,et al. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. , 2006, Clinical hemorheology and microcirculation.
[209] L. Bastholt,et al. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. , 2000, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[210] Li Lin,et al. New curcumin analogues exhibit enhanced growth‐suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells , 2009, Cancer science.
[211] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[212] L. O’Neill,et al. Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. , 1998, Biochemical pharmacology.
[213] G. Tortora,et al. Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy. , 2007, Differentiation; research in biological diversity.
[214] T. Giordano,et al. Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer. , 2007, Cancer research.
[215] M. Karin,et al. AP-1 in cell proliferation and survival , 2001, Oncogene.
[216] S. Pal,et al. Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner* , 2005, Journal of Biological Chemistry.
[217] A. Méjean,et al. Inhibiteurs de l’angiogenèse : revues de l’apport thérapeutique du sorafenib, du sunitinib et du bevacizumab dans le cancer du rein métastatique , 2010 .
[218] B. Aggarwal,et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX‐2, MMP‐9, VEGF and CXCR4 expression in an orthotopic mouse model , 2009, International journal of cancer.
[219] A J Cmelak,et al. Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[220] E. Srivatsan,et al. Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway , 2010, Molecular Cancer Therapeutics.
[221] B. Aggarwal,et al. The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.
[222] T. Osawa,et al. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. , 1999, Carcinogenesis.
[223] S. Syrjänen. The role of human papillomavirus infection in head and neck cancers. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[224] M. Sata,et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[225] Zhenghong Qin,et al. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. , 2009, Acta biochimica et biophysica Sinica.
[226] Mariela C. Marazita,et al. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions , 2007, IUBMB life.
[227] T. P. Krishna,et al. Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. , 1998, Nutrition and cancer.